menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    CytRx, Nantcell Strike Licensing Agreement for Aldoxorubicin

    DDDMAG

    Soon-Shiong’s NantCell in $356M deal for underperforming CytRx cancer drug

    FIERCE BIOTECH

    CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up

    NASDAQ

    BRIEF-Cytrx says FDA agreement on regulatory pathway for Aldoxorubicin

    REUTERS

    CytRx Plans to File NDA for Once-Failed Sarcoma Drug

    BIOSPACE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.